Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024166 · ClinicalTrials.gov registry record
Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT01024166: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01024166 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01024166 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The goal of this research study is to learn if palliative care patients or caregivers, and palliative care physicians or nurses can use a computer program designed to provide information about the symptoms and overall health of cancer patients.
Interventions
- BEHAVIORAL Questionnaire and Review Session
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-06 |
What the finished NCT01024166 record still lists
NCT01024166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire and Review Session is the first listed.
NCT01024166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01024166 about?
NCT01024166 is a clinical study titled "Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study". The goal of this research study is to learn if palliative care patients or caregivers, and palliative care physicians or nurses can use a computer program designed to provide information about the symptoms and overall health of cancer patients.
What is the current status of trial NCT01024166?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2009-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01024166?
The interventions under investigation include: Questionnaire and Review Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT01024166?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia